HEADER TRANSFERASE 13-JAN-00 1DTU TITLE BACILLUS CIRCULANS STRAIN 251 CYCLODEXTRIN GLYCOSYLTRANSFERASE: A TITLE 2 MUTANT Y89D/S146P COMPLEXED TO AN HEXASACCHARIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (CYCLODEXTRIN GLYCOSYLTRANSFERASE); COMPND 3 CHAIN: A; COMPND 4 EC: 2.4.1.19; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS CIRCULANS; SOURCE 3 ORGANISM_TAXID: 1397; SOURCE 4 STRAIN: 251; SOURCE 5 CELLULAR_LOCATION: EXTRACELLULAR; SOURCE 6 EXPRESSION_SYSTEM: BACILLUS SUBTILIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 1423; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PDP66S KEYWDS ALPHA-AMYLASE, ACARBOSE, INHIBITOR COMPLEX, FAMILY 13 GLYCOSYL KEYWDS 2 HYDROLASE, MUTANT, PRODUCT SPECIFICITY, CYCLODEXTRIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.C.M.UITDEHAAG,K.H.KALK,B.W.DIJKSTRA REVDAT 8 30-OCT-24 1DTU 1 REMARK REVDAT 7 09-AUG-23 1DTU 1 REMARK REVDAT 6 03-NOV-21 1DTU 1 SEQADV HETSYN REVDAT 5 29-JUL-20 1DTU 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE ATOM REVDAT 4 25-OCT-17 1DTU 1 HETSYN LINK ATOM REVDAT 3 24-FEB-09 1DTU 1 VERSN REVDAT 2 01-APR-03 1DTU 1 JRNL REVDAT 1 06-MAR-00 1DTU 0 JRNL AUTH B.A.VAN DER VEEN,J.C.UITDEHAAG,D.PENNINGA,G.J.VAN ALEBEEK, JRNL AUTH 2 L.M.SMITH,B.W.DIJKSTRA,L.DIJKHUIZEN JRNL TITL RATIONAL DESIGN OF CYCLODEXTRIN GLYCOSYLTRANSFERASE FROM JRNL TITL 2 BACILLUS CIRCULANS STRAIN 251 TO INCREASE ALPHA-CYCLODEXTRIN JRNL TITL 3 PRODUCTION. JRNL REF J.MOL.BIOL. V. 296 1027 2000 JRNL REFN ISSN 0022-2836 JRNL PMID 10686101 JRNL DOI 10.1006/JMBI.2000.3528 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.D.WIND,J.C.M.UITDEHAAG,R.M.BUITELAAR,B.W.DIJKSTRA, REMARK 1 AUTH 2 L.DIJKHUIZEN REMARK 1 TITL ENGINEERING OF CYCLODEXTRIN PRODUCT SPECIFICITY AND PH REMARK 1 TITL 2 OPTIMA OF THE THERMOSTABLE CYCLODEXTRIN GLYCOSYLTRANSFERASE REMARK 1 TITL 3 FROM THERMOANAEROBACTERIUM THERMOSULFURIGENES EM1 REMARK 1 REF J.BIOL.CHEM. V. 273 5771 1998 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.273.10.5771 REMARK 1 REFERENCE 2 REMARK 1 AUTH B.STROKOPYTOV,R.M.KNEGTEL,D.PENNINGA,H.J.ROZEBOOM,K.H.KALK, REMARK 1 AUTH 2 L.DIJKHUIZEN,B.W.DIJKSTRA REMARK 1 TITL STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE COMPLEXED WITH REMARK 1 TITL 2 A MALTONONAOSE INHIBITOR AT 2.6 ANGSTROM RESOLUTION. REMARK 1 TITL 3 IMPLICATIONS FOR PRODUCT SPECIFICITY REMARK 1 REF BIOCHEMISTRY V. 35 4241 1996 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI952339H REMARK 1 REFERENCE 3 REMARK 1 AUTH D.PENNINGA,B.STROKOPYTOV,H.J.ROZEBOOM,C.L.LAWSON, REMARK 1 AUTH 2 B.W.DIJKSTRA,J.BERGSMA,L.DIJKHUIZEN REMARK 1 TITL SITE DIRECTED MUTAGENESIS IN TYROSINE 195 OF CYCLODEXTRIN REMARK 1 TITL 2 GLYCOSYLTRANSFERASE FROM BACILLUS CIRCULANS STRAIN 251 REMARK 1 TITL 3 AFFECT ACTIVITY AND PRODUCT SPECIFICITY REMARK 1 REF BIOCHEMISTRY V. 34 3368 1995 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 3 NUMBER OF REFLECTIONS : 32700 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : RFREE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2171 REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2090 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2060 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 6.00 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2171 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 32641 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5261 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 181 REMARK 3 SOLVENT ATOMS : 273 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 22.900 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.002 ; NULL ; 5591 REMARK 3 BOND ANGLES (DEGREES) : 1.150 ; NULL ; 7617 REMARK 3 TORSION ANGLES (DEGREES) : 17.135; NULL ; 3136 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.002 ; NULL ; 148 REMARK 3 GENERAL PLANES (A) : 0.010 ; NULL ; 796 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 1.413 ; NULL ; 5588 REMARK 3 NON-BONDED CONTACTS (A) : 0.009 ; NULL ; 287 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : TNT STANDARD LIBRARY (PRE-PRIESTLE VERSION) REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : TNT STANDARD LIBRARY REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 STEREOCHEMISTRY TARGETS IN GENERAL CORRESPOND TO ENGH&HUBER REMARK 3 THE ELECTRON DENSITY IMPOSES NON-IDEAL STEREOCHEMISTRY REMARK 3 OF THE C1-N1 BOND AND C5 COORDINATION OF ACARVIOSINE IN REMARK 3 SUBSITE -1. THIS MIGHT REFLECT PRESENCE OF MULTIPLE REMARK 3 CHEMICAL SPECIES. THE RESOLUTION IS TOO LOW TO RESOLVE REMARK 3 THIS. THE SIDE-CHAIN OF RESIDUE ARG 47 WAS MODELLED IN REMARK 3 2 CONFORMATIONS WITH 50% OCCUPANCY EACH. REMARK 4 REMARK 4 1DTU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JAN-00. REMARK 100 THE DEPOSITION ID IS D_1000010360. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAR-96 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 7.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR571 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MACSCIENCE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : BIOMOL, XDS REMARK 200 DATA SCALING SOFTWARE : XDS, BIOMOL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32700 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 28.860 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 4.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.07470 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.44 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.25600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: TNT REMARK 200 STARTING MODEL: 1CXG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 60 % MPD, 100 MM TRIS PH 7.1, 5% (W/V) REMARK 280 MALTOSE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 60.22250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.87900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.58000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 32.87900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 60.22250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.58000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 63 CB - CG - OD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 ASP A 104 CB - CG - OD1 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 104 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 ASP A 117 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 135 CB - CG - OD1 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP A 135 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP A 147 CB - CG - OD2 ANGL. DEV. = -6.1 DEGREES REMARK 500 ASP A 159 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 170 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 199 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 213 CB - CG - OD2 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASP A 224 CB - CG - OD2 ANGL. DEV. = -5.6 DEGREES REMARK 500 ASP A 229 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 298 CB - CG - OD1 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP A 298 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ASP A 318 CB - CG - OD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 ASP A 328 CB - CG - OD1 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 328 CB - CG - OD2 ANGL. DEV. = -6.5 DEGREES REMARK 500 ASP A 371 CB - CG - OD2 ANGL. DEV. = -6.1 DEGREES REMARK 500 ASP A 373 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 458 CB - CG - OD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 ASP A 518 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 546 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 585 CB - CG - OD2 ANGL. DEV. = -5.9 DEGREES REMARK 500 ASP A 617 CB - CG - OD2 ANGL. DEV. = -5.5 DEGREES REMARK 500 ASP A 639 CB - CG - OD2 ANGL. DEV. = -5.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 25 -72.68 -97.91 REMARK 500 ALA A 96 34.15 -86.75 REMARK 500 TRP A 101 70.07 -107.40 REMARK 500 ALA A 137 77.50 -118.45 REMARK 500 THR A 141 -87.72 -110.01 REMARK 500 ALA A 152 -132.54 56.44 REMARK 500 ASN A 169 30.29 75.06 REMARK 500 ASP A 170 77.75 -68.54 REMARK 500 ASN A 173 47.11 73.65 REMARK 500 TYR A 195 -122.63 73.28 REMARK 500 TYR A 249 -70.39 -122.40 REMARK 500 ARG A 294 -68.42 -98.72 REMARK 500 ASN A 299 -167.31 -110.56 REMARK 500 TRP A 413 129.95 -174.61 REMARK 500 LEU A 464 40.75 -108.12 REMARK 500 SER A 573 -168.33 -100.78 REMARK 500 ASN A 627 26.18 -164.54 REMARK 500 VAL A 629 -83.45 -71.57 REMARK 500 PRO A 634 28.40 -76.03 REMARK 500 TYR A 638 136.89 -174.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 687 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 27 OD1 REMARK 620 2 ASN A 29 O 80.6 REMARK 620 3 ASN A 32 OD1 145.7 65.2 REMARK 620 4 ASN A 33 OD1 89.7 99.7 98.4 REMARK 620 5 GLY A 51 O 75.4 153.1 136.8 92.4 REMARK 620 6 ASP A 53 OD2 78.3 75.0 89.7 167.4 88.1 REMARK 620 7 HOH A 754 O 142.6 135.9 71.6 77.9 70.0 113.9 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 688 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 139 OD1 REMARK 620 2 ILE A 190 O 155.8 REMARK 620 3 ASP A 199 OD1 77.9 119.8 REMARK 620 4 ASP A 199 OD2 123.1 80.4 51.2 REMARK 620 5 HIS A 233 O 76.5 80.0 143.3 160.4 REMARK 620 6 HOH A 743 O 94.0 77.3 73.5 93.9 82.6 REMARK 620 7 HOH A 768 O 67.6 128.7 79.3 78.4 113.8 149.9 REMARK 620 8 HOH A 862 O 115.5 66.4 132.4 88.7 82.8 142.7 66.9 REMARK 620 N 1 2 3 4 5 6 7 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A47 RELATED DB: PDB REMARK 900 THERMOANAEROBACTERIUM THERMOSULFURIGENES CGTASE COMPLEXED TO AN REMARK 900 HEXASACCHARIDE INHIBITOR REMARK 900 RELATED ID: 2CXG RELATED DB: PDB REMARK 900 WILD TYPE BACILLUS CIRCULANS STRAIN 251 CGTASE COMPLEXED TO AN REMARK 900 ACARBOSE-DERIVED TETRASACCHARIDE INHIBITOR REMARK 900 RELATED ID: 2DIJ RELATED DB: PDB REMARK 900 WILD TYPE BACILLUS CIRCULANS STRAIN 251 CGTASE COMPLEXED TO AN REMARK 900 ACARBOSE-DERIVED NONASACCHARIDE INHIBITOR REMARK 900 RELATED ID: 1CDG RELATED DB: PDB REMARK 900 WILD TYPE BACILLUS CIRCULANS STRAIN 251 CGTASE DBREF 1DTU A 1 686 UNP P43379 CDGU_BACCI 28 713 SEQADV 1DTU ASP A 89 UNP P43379 TYR 116 ENGINEERED MUTATION SEQADV 1DTU PRO A 146 UNP P43379 SER 173 ENGINEERED MUTATION SEQRES 1 A 686 ALA PRO ASP THR SER VAL SER ASN LYS GLN ASN PHE SER SEQRES 2 A 686 THR ASP VAL ILE TYR GLN ILE PHE THR ASP ARG PHE SER SEQRES 3 A 686 ASP GLY ASN PRO ALA ASN ASN PRO THR GLY ALA ALA PHE SEQRES 4 A 686 ASP GLY THR CYS THR ASN LEU ARG LEU TYR CYS GLY GLY SEQRES 5 A 686 ASP TRP GLN GLY ILE ILE ASN LYS ILE ASN ASP GLY TYR SEQRES 6 A 686 LEU THR GLY MET GLY VAL THR ALA ILE TRP ILE SER GLN SEQRES 7 A 686 PRO VAL GLU ASN ILE TYR SER ILE ILE ASN ASP SER GLY SEQRES 8 A 686 VAL ASN ASN THR ALA TYR HIS GLY TYR TRP ALA ARG ASP SEQRES 9 A 686 PHE LYS LYS THR ASN PRO ALA TYR GLY THR ILE ALA ASP SEQRES 10 A 686 PHE GLN ASN LEU ILE ALA ALA ALA HIS ALA LYS ASN ILE SEQRES 11 A 686 LYS VAL ILE ILE ASP PHE ALA PRO ASN HIS THR SER PRO SEQRES 12 A 686 ALA SER PRO ASP GLN PRO SER PHE ALA GLU ASN GLY ARG SEQRES 13 A 686 LEU TYR ASP ASN GLY THR LEU LEU GLY GLY TYR THR ASN SEQRES 14 A 686 ASP THR GLN ASN LEU PHE HIS HIS ASN GLY GLY THR ASP SEQRES 15 A 686 PHE SER THR THR GLU ASN GLY ILE TYR LYS ASN LEU TYR SEQRES 16 A 686 ASP LEU ALA ASP LEU ASN HIS ASN ASN SER THR VAL ASP SEQRES 17 A 686 VAL TYR LEU LYS ASP ALA ILE LYS MET TRP LEU ASP LEU SEQRES 18 A 686 GLY ILE ASP GLY ILE ARG MET ASP ALA VAL LYS HIS MET SEQRES 19 A 686 PRO PHE GLY TRP GLN LYS SER PHE MET ALA ALA VAL ASN SEQRES 20 A 686 ASN TYR LYS PRO VAL PHE THR PHE GLY GLU TRP PHE LEU SEQRES 21 A 686 GLY VAL ASN GLU VAL SER PRO GLU ASN HIS LYS PHE ALA SEQRES 22 A 686 ASN GLU SER GLY MET SER LEU LEU ASP PHE ARG PHE ALA SEQRES 23 A 686 GLN LYS VAL ARG GLN VAL PHE ARG ASP ASN THR ASP ASN SEQRES 24 A 686 MET TYR GLY LEU LYS ALA MET LEU GLU GLY SER ALA ALA SEQRES 25 A 686 ASP TYR ALA GLN VAL ASP ASP GLN VAL THR PHE ILE ASP SEQRES 26 A 686 ASN HIS ASP MET GLU ARG PHE HIS ALA SER ASN ALA ASN SEQRES 27 A 686 ARG ARG LYS LEU GLU GLN ALA LEU ALA PHE THR LEU THR SEQRES 28 A 686 SER ARG GLY VAL PRO ALA ILE TYR TYR GLY THR GLU GLN SEQRES 29 A 686 TYR MET SER GLY GLY THR ASP PRO ASP ASN ARG ALA ARG SEQRES 30 A 686 ILE PRO SER PHE SER THR SER THR THR ALA TYR GLN VAL SEQRES 31 A 686 ILE GLN LYS LEU ALA PRO LEU ARG LYS CYS ASN PRO ALA SEQRES 32 A 686 ILE ALA TYR GLY SER THR GLN GLU ARG TRP ILE ASN ASN SEQRES 33 A 686 ASP VAL LEU ILE TYR GLU ARG LYS PHE GLY SER ASN VAL SEQRES 34 A 686 ALA VAL VAL ALA VAL ASN ARG ASN LEU ASN ALA PRO ALA SEQRES 35 A 686 SER ILE SER GLY LEU VAL THR SER LEU PRO GLN GLY SER SEQRES 36 A 686 TYR ASN ASP VAL LEU GLY GLY LEU LEU ASN GLY ASN THR SEQRES 37 A 686 LEU SER VAL GLY SER GLY GLY ALA ALA SER ASN PHE THR SEQRES 38 A 686 LEU ALA ALA GLY GLY THR ALA VAL TRP GLN TYR THR ALA SEQRES 39 A 686 ALA THR ALA THR PRO THR ILE GLY HIS VAL GLY PRO MET SEQRES 40 A 686 MET ALA LYS PRO GLY VAL THR ILE THR ILE ASP GLY ARG SEQRES 41 A 686 GLY PHE GLY SER SER LYS GLY THR VAL TYR PHE GLY THR SEQRES 42 A 686 THR ALA VAL SER GLY ALA ASP ILE THR SER TRP GLU ASP SEQRES 43 A 686 THR GLN ILE LYS VAL LYS ILE PRO ALA VAL ALA GLY GLY SEQRES 44 A 686 ASN TYR ASN ILE LYS VAL ALA ASN ALA ALA GLY THR ALA SEQRES 45 A 686 SER ASN VAL TYR ASP ASN PHE GLU VAL LEU SER GLY ASP SEQRES 46 A 686 GLN VAL SER VAL ARG PHE VAL VAL ASN ASN ALA THR THR SEQRES 47 A 686 ALA LEU GLY GLN ASN VAL TYR LEU THR GLY SER VAL SER SEQRES 48 A 686 GLU LEU GLY ASN TRP ASP PRO ALA LYS ALA ILE GLY PRO SEQRES 49 A 686 MET TYR ASN GLN VAL VAL TYR GLN TYR PRO ASN TRP TYR SEQRES 50 A 686 TYR ASP VAL SER VAL PRO ALA GLY LYS THR ILE GLU PHE SEQRES 51 A 686 LYS PHE LEU LYS LYS GLN GLY SER THR VAL THR TRP GLU SEQRES 52 A 686 GLY GLY SER ASN HIS THR PHE THR ALA PRO SER SER GLY SEQRES 53 A 686 THR ALA THR ILE ASN VAL ASN TRP GLN PRO HET GLC B 1 12 HET GLC B 2 11 HET GLC C 1 12 HET G6D C 2 9 HET GLC D 1 12 HET GLC D 2 11 HET GLC D 3 11 HET BGC E 1 12 HET GLC E 2 11 HET GLC E 3 11 HET GLC E 4 11 HET GLC E 5 11 HET GLC F 1 12 HET GLC F 2 11 HET GLC F 3 11 HET CA A 687 1 HET CA A 688 1 HET ADH A 693 11 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM G6D ALPHA-D-QUINOVOPYRANOSE HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM CA CALCIUM ION HETNAM ADH 1-AMINO-2,3-DIHYDROXY-5-HYDROXYMETHYL CYCLOHEX-5-ENE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN G6D ALPHA-D-QUINOVOSE; 6-DEOXY-ALPHA-D-GLUCOPYRANOSE; D- HETSYN 2 G6D QUINOVOSE; QUINOVOSE; 6-DEOXY-ALPHA-D-GLUCOSE HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 GLC 13(C6 H12 O6) FORMUL 3 G6D C6 H12 O5 FORMUL 5 BGC C6 H12 O6 FORMUL 7 CA 2(CA 2+) FORMUL 9 ADH C7 H13 N O3 FORMUL 10 HOH *273(H2 O) HELIX 1 1 PHE A 21 PHE A 25 5 5 HELIX 2 2 ASN A 29 ASN A 33 5 5 HELIX 3 3 THR A 35 ALA A 38 5 4 HELIX 4 4 ASP A 53 ASP A 63 1 11 HELIX 5 5 GLY A 64 GLY A 70 1 7 HELIX 6 6 THR A 114 LYS A 128 1 15 HELIX 7 7 THR A 185 LYS A 192 1 8 HELIX 8 8 ASN A 204 LEU A 221 1 18 HELIX 9 9 ALA A 230 MET A 234 5 5 HELIX 10 10 PRO A 235 ASN A 248 1 14 HELIX 11 11 SER A 266 SER A 276 1 11 HELIX 12 12 ASP A 282 ARG A 294 1 13 HELIX 13 13 ASN A 299 TYR A 314 1 16 HELIX 14 14 GLN A 316 ASP A 319 5 4 HELIX 15 15 ARG A 339 THR A 351 1 13 HELIX 16 16 GLY A 361 TYR A 365 5 5 HELIX 17 17 THR A 385 ALA A 395 1 11 HELIX 18 18 PRO A 396 ASN A 401 1 6 HELIX 19 19 ASN A 401 GLY A 407 1 7 HELIX 20 20 GLY A 472 GLY A 475 5 4 HELIX 21 21 SER A 537 ALA A 539 5 3 HELIX 22 22 VAL A 610 GLY A 614 5 5 HELIX 23 23 ASP A 617 ALA A 621 5 5 SHEET 1 A 8 SER A 279 LEU A 280 0 SHEET 2 A 8 PHE A 253 GLY A 256 1 O THR A 254 N SER A 279 SHEET 3 A 8 GLY A 225 MET A 228 1 N ILE A 226 O PHE A 253 SHEET 4 A 8 LYS A 131 PHE A 136 1 O VAL A 132 N GLY A 225 SHEET 5 A 8 ALA A 73 ILE A 76 1 O ILE A 74 N ILE A 133 SHEET 6 A 8 ILE A 17 ILE A 20 1 O TYR A 18 N TRP A 75 SHEET 7 A 8 VAL A 355 TYR A 359 1 O PRO A 356 N ILE A 17 SHEET 8 A 8 VAL A 321 THR A 322 1 O THR A 322 N ALA A 357 SHEET 1 B 2 VAL A 80 ASN A 82 0 SHEET 2 B 2 ALA A 102 THR A 108 -1 N ARG A 103 O GLU A 81 SHEET 1 C 2 ILE A 87 ASP A 89 0 SHEET 2 C 2 VAL A 92 ASN A 94 -1 O VAL A 92 N ASP A 89 SHEET 1 D 2 HIS A 140 PRO A 143 0 SHEET 2 D 2 LEU A 197 ASP A 199 -1 N ALA A 198 O SER A 142 SHEET 1 E 2 LEU A 157 ASP A 159 0 SHEET 2 E 2 THR A 162 GLY A 165 -1 O THR A 162 N ASP A 159 SHEET 1 F 4 SER A 408 ILE A 414 0 SHEET 2 F 4 VAL A 418 PHE A 425 -1 O ILE A 420 N ARG A 412 SHEET 3 F 4 ASN A 428 ASN A 435 -1 O ASN A 428 N PHE A 425 SHEET 4 F 4 THR A 487 TYR A 492 -1 O ALA A 488 N ALA A 433 SHEET 1 G 2 ALA A 442 ILE A 444 0 SHEET 2 G 2 PHE A 480 LEU A 482 -1 O PHE A 480 N ILE A 444 SHEET 1 H 2 GLY A 454 TYR A 456 0 SHEET 2 H 2 LEU A 469 VAL A 471 -1 O LEU A 469 N TYR A 456 SHEET 1 I 4 THR A 500 GLY A 505 0 SHEET 2 I 4 THR A 514 ARG A 520 -1 N THR A 516 O GLY A 505 SHEET 3 I 4 GLN A 548 LYS A 552 -1 O ILE A 549 N ILE A 517 SHEET 4 I 4 ILE A 541 TRP A 544 -1 N THR A 542 O LYS A 550 SHEET 1 J 5 MET A 508 ALA A 509 0 SHEET 2 J 5 TYR A 576 VAL A 581 1 O GLU A 580 N ALA A 509 SHEET 3 J 5 GLY A 559 ALA A 566 -1 O GLY A 559 N VAL A 581 SHEET 4 J 5 THR A 528 PHE A 531 -1 N THR A 528 O ALA A 566 SHEET 5 J 5 THR A 534 VAL A 536 -1 O THR A 534 N PHE A 531 SHEET 1 K 3 TRP A 636 PRO A 643 0 SHEET 2 K 3 GLN A 586 ASN A 594 -1 N VAL A 587 O VAL A 642 SHEET 3 K 3 ALA A 678 ASN A 683 1 O ALA A 678 N ARG A 590 SHEET 1 L 3 ASN A 603 GLY A 608 0 SHEET 2 L 3 THR A 647 GLN A 656 -1 O LYS A 651 N THR A 607 SHEET 3 L 3 THR A 659 TRP A 662 -1 N THR A 659 O GLN A 656 SHEET 1 M 3 ASN A 603 GLY A 608 0 SHEET 2 M 3 THR A 647 GLN A 656 -1 O LYS A 651 N THR A 607 SHEET 3 M 3 HIS A 668 THR A 671 -1 N HIS A 668 O PHE A 650 SSBOND 1 CYS A 43 CYS A 50 1555 1555 2.03 LINK N1 ADH A 693 C4 G6D C 2 1555 1555 1.76 LINK C4 ADH A 693 O1 GLC D 1 1555 1555 1.44 LINK O4 GLC B 1 C1 GLC B 2 1555 1555 1.41 LINK O4 GLC C 1 C1 G6D C 2 1555 1555 1.41 LINK O4 GLC D 1 C1 GLC D 2 1555 1555 1.41 LINK O4 GLC D 2 C1 GLC D 3 1555 1555 1.41 LINK O4 BGC E 1 C1 GLC E 2 1555 1555 1.41 LINK O4 GLC E 2 C1 GLC E 3 1555 1555 1.41 LINK O4 GLC E 3 C1 GLC E 4 1555 1555 1.41 LINK O4 GLC E 4 C1 GLC E 5 1555 1555 1.41 LINK O4 GLC F 1 C1 GLC F 2 1555 1555 1.41 LINK O4 GLC F 2 C1 GLC F 3 1555 1555 1.41 LINK OD1 ASP A 27 CA CA A 687 1555 1555 2.32 LINK O ASN A 29 CA CA A 687 1555 1555 2.59 LINK OD1 ASN A 32 CA CA A 687 1555 1555 2.43 LINK OD1 ASN A 33 CA CA A 687 1555 1555 2.16 LINK O GLY A 51 CA CA A 687 1555 1555 2.53 LINK OD2 ASP A 53 CA CA A 687 1555 1555 2.51 LINK OD1 ASN A 139 CA CA A 688 1555 1555 2.37 LINK O ILE A 190 CA CA A 688 1555 1555 2.64 LINK OD1 ASP A 199 CA CA A 688 1555 1555 2.49 LINK OD2 ASP A 199 CA CA A 688 1555 1555 2.66 LINK O HIS A 233 CA CA A 688 1555 1555 2.34 LINK CA CA A 687 O HOH A 754 1555 1555 2.41 LINK CA CA A 688 O HOH A 743 1555 1555 2.64 LINK CA CA A 688 O HOH A 768 1555 1555 2.48 LINK CA CA A 688 O HOH A 862 1555 1555 2.41 CISPEP 1 ASP A 371 PRO A 372 0 4.63 CISPEP 2 GLY A 505 PRO A 506 0 0.25 CISPEP 3 GLY A 623 PRO A 624 0 1.37 CISPEP 4 TYR A 633 PRO A 634 0 3.23 CRYST1 120.445 111.160 65.758 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008303 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008996 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015207 0.00000